Identification, Design and Bio-Evaluation of Novel Hsp90 Inhibitors by Ligand-Based Virtual Screening

• JianMin Jia ,

  Contributed equally to this work with: JianMin Jia, XiaoLi Xu

  Affiliations State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China, Jiang Su Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing, China

  ⨯
• XiaoLi Xu ,

  Contributed equally to this work with: JianMin Jia, XiaoLi Xu

  Affiliations State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China, Jiang Su Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing, China

  ⨯
• Fang Liu,

  Affiliations State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China, Jiang Su Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing, China

  ⨯
• XiaoKe Guo,

  Affiliations State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China, Jiang Su Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing, China

  ⨯
• MingYe Zhang,

  Affiliations State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China, Jiang Su Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing, China

  ⨯
• MengChen Lu,

  Affiliations State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China, Jiang Su Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing, China

  ⨯
• LiLi Xu,

  Affiliations State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China, Jiang Su Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing, China

  ⨯
• JinLian Wei,

  Affiliations State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China, Jiang Su Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing, China

  ⨯
• Jia Zhu,

  Affiliations State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China, Jiang Su Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing, China

  ⨯
• ShengLie Zhang,

  Affiliations State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China, Jiang Su Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing, China

  ⨯
• ShengMiao Zhang,

  Affiliations State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China, Jiang Su Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing, China

  ⨯
• HaoPeng Sun ,

  * E-mail: sunhaopeng@163.com (HPS); youqidong@gmail.com (QDY)

  Affiliations State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China, Jiang Su Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing, China, Department of Medicinal Chemistry, China Pharmaceutical University, Nanjing, China

  ⨯
• QiDong You

  * E-mail: sunhaopeng@163.com (HPS); youqidong@gmail.com (QDY)

  Affiliations State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China, Jiang Su Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing, China

  ⨯